Danaher PT receives Investment Bank Analyst Rating Update
By Liz Moyer Investing.com -- U.S. stocks wobbled on Thursday after a strong retail sales report and a better than expected number on jobless claims. Here are the midday movers for...
Pre-Open Stock Movers: Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in...
Many growth stocks and exchange-traded funds (ETFs) are currently changing hands around 52-week or even multi-year lows and the impending earnings season could bring more...
This article was written exclusively for Investing.com On Oct. 1, 2018, Larry Culp took over as chief executive officer of General Electric (NYSE:GE). Since the close of trading...
Escalating geopolitical tensions in Eastern Europe have added to recent market volatility. And with the probability of harsher sanctions against Russia now in play, after President...
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.
|Average||320.65 (+13.59% Upside)|
|No. of Analysts||23|